about
C-reactive protein does not opsonize early apoptotic human neutrophils, but binds only membrane-permeable late apoptotic cells and has no effect on their phagocytosis by macrophagesCyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosisYou can lead a macrophage to an inflammatory site but can you make it eat?Pharmacological manipulation of granulocyte apoptosis: potential therapeutic targets.Influenza virus A infection of human monocyte and macrophage subpopulations reveals increased susceptibility associated with cell differentiation.A blast from the past: clearance of apoptotic cells regulates immune responses.Characterization of the effects of cross-linking of macrophage CD44 associated with increased phagocytosis of apoptotic PMN.Diversification of TAM receptor tyrosine kinase functionRole of leukotrienes in the regulation of human granulocyte behaviour: dissociation between agonist-induced activation and retardation of apoptosis.Glucocorticoid-mediated regulation of granulocyte apoptosis and macrophage phagocytosis of apoptotic cells: implications for the resolution of inflammation.Regulation of granulocyte apoptosis by hemopoietic growth factors, cytokines and drugs: potential relevance to allergic inflammation.Circulating IgM Requires Plasma Membrane Disruption to Bind Apoptotic and Non-Apoptotic Nucleated Cells and Erythrocytes.Granulocyte apoptosis: who would work with a 'real' inflammatory cell?Regulation of granulocyte apoptosis by NF-kappaB.Regulation of neutrophil apoptosis and removal of apoptotic cells.Susceptibility of bone marrow-derived macrophages to influenza virus infection is dependent on macrophage phenotype.N-Acetylcysteine inhibits platelet-monocyte conjugation in patients with type 2 diabetes with depleted intraplatelet glutathione: a randomised controlled trial.Mer receptor tyrosine kinase mediates both tethering and phagocytosis of apoptotic cells.Early events of the immune response mediated by leukocyte integrins.Clearance of dying cells and autoimmunity.Phagocytosis of apoptotic cells.Functional and clinical consequences of Fc receptor polymorphic and copy number variants.The importance of the macrophage within the human endometrium.Eosinophils in the lung - modulating apoptosis and efferocytosis in airway inflammation.Axl and Mer Receptor Tyrosine Kinases: Distinct and Nonoverlapping Roles in Inflammation and Cancer?Non-canonical PI3K-Cdc42-Pak-Mek-Erk Signaling Promotes Immune-Complex-Induced Apoptosis in Human Neutrophils.Granulocyte apoptosis and the control of inflammation.Recognition of apoptotic cells by phagocytes.A critical 'threshold' of beta 2-integrin engagement regulates augmentation of cytokine-mediated superoxide anion release.Specific binding of an antigen-antibody complex to apoptotic human neutrophils.Inhibition of neuropeptide-stimulated tyrosine phosphorylation and tyrosine kinase activity stimulates apoptosis in small cell lung cancer cells.Peritonitis activates transcription of the human prolactin locus in myeloid cells in a humanized transgenic rat model.The uncoupling of monocyte-platelet interactions from the induction of proinflammatory signaling in monocytes.Cyclic AMP regulation of neutrophil apoptosis occurs via a novel protein kinase A-independent signaling pathway.Inhibition of nuclear factor-kappaB activation un-masks the ability of TNF-alpha to induce human eosinophil apoptosis.Phagocytosis of apoptotic cells by human macrophages: analysis by multiparameter flow cytometry.Association of FcgammaRIIa (CD32a) with lipid rafts regulates ligand binding activity.Interleukin-10 inhibits lipopolysaccharide-induced survival and extracellular signal-regulated kinase activation in human neutrophils.Choice of anticoagulant critically affects measurement of circulating platelet-leukocyte complexes.Assessment of neutrophil apoptosis.
P50
Q24813654-55E17603-DCB4-4890-9E91-A9F8C17066CFQ28261784-F6FAFF0D-C0D7-480F-8B1D-4E8A32DD6781Q33536681-033FC659-BABA-4D3B-B49B-463AB3CBFE18Q33798112-02C32E59-D09A-499B-93E2-831DC6578423Q34125085-A2B3FBA5-B61D-4CE5-BE04-86DFDBC4B26EQ34162195-5F0437FC-59E0-4378-9069-3B6070AEE572Q34200530-32666F49-D779-4890-8FF3-C1B7795AD2B3Q34214465-CA3E4AF1-6069-42A9-8E87-4D8B2D2467FBQ35045349-D3CD06ED-F0EB-4F3E-8DEB-2E704C6BCE93Q35170061-480307CF-F5FA-4E73-8713-BEC36D16DC68Q35560493-14F3294C-4EC6-47F5-AD5C-22214D369E71Q35677438-4490BE9F-DD3A-49C7-AA4F-80E0F2B093EFQ35780442-DB63C350-9801-4E6F-B5A9-F7CFC216A137Q35780459-43C11984-1243-467F-B1A0-C4431F82DBA7Q36230403-6AA8547C-6A8A-4107-8036-4EA48E5CB7BEQ36255054-6395788F-6B54-40EA-9E6F-0CA2566BEA01Q36297823-E36F4CB4-DA91-45CF-B17C-830AAE838A0BQ36347294-8FEAC179-73C6-4D41-BC01-E18F14F94262Q36585120-2167083A-5C32-4033-AA03-DAED54912040Q36827926-8F57BBBE-F7FC-436C-8180-89870B739A6CQ37099932-E933A88C-99F4-4C1B-9961-24B770482A1EQ37552028-B851DE5A-64A6-4D36-B889-FE8ACD21E5A5Q38056338-14FF3FBE-C159-4B40-AF3B-24E6E5EDAD14Q38234940-EB08A7B1-7790-4B0A-8063-DF94EC473E41Q38936702-9593996A-3532-47DB-9515-EB2E2897B8D1Q40516211-9D690634-00C4-4541-9F62-4594848DC504Q40585961-1204028B-F706-4E0F-B097-337EF50F64F5Q41210973-5077B782-533D-46B0-8F70-D84E7EEC3332Q41867283-47FE7D41-53C7-4750-A725-A3B910FED27AQ41897494-7FB2FBE9-BA10-4018-845A-8D1B57A022F8Q42522900-9B5B0158-A66B-47D4-BBAD-1A68008889B7Q43445741-0BC7E72D-6F4F-40A3-9617-5B00EC72E3EAQ43501110-DF3A9976-04C4-492D-A23E-5BC50F314937Q43740247-13DCFB63-2723-42E5-B55F-7B88E9E5675EQ43867812-04874F09-EE44-458A-875E-D7B97B4B1B13Q44261279-E47AF1C8-E8F5-4EF5-87F6-60F52CB44616Q45983835-60DCEDD3-6571-4459-848B-5F08AE6E573BQ46655428-D5C39059-439D-4A49-86C9-DFEEB8BE5070Q46840526-D98D5DB7-C8D3-42EA-B971-3C8A6D10CD1FQ46935020-3BE46FB7-6040-4BF4-A34D-5AF2958BBEAC
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-5848-7059
@en
name
Ian Dransfield
@ast
Ian Dransfield
@en
Ian Dransfield
@es
Ian Dransfield
@nl
type
label
Ian Dransfield
@ast
Ian Dransfield
@en
Ian Dransfield
@es
Ian Dransfield
@nl
prefLabel
Ian Dransfield
@ast
Ian Dransfield
@en
Ian Dransfield
@es
Ian Dransfield
@nl
P106
P31
P496
0000-0001-5848-7059